文献速递生殖医学妇科

对BRCA1突变卵巢癌患者离体取卵并冷冻保存卵母细胞以保留生育力

Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer.
PubMed 文献 · Fertil Steril · 2017-06-16

一例37岁BRCA1突变卵巢癌可疑患者,因常规取卵可能破坏卵巢包膜致恶性细胞溢出,改在手术分期时行离体取卵。经黄体期促性腺激素联合来曲唑刺激,于触发后34小时手术,从双侧卵巢切除标本中获得7枚成熟卵母细胞并玻璃化冷冻,同期完成手术分期。作者认为该法可行,可降低恶性细胞溢出和肿瘤分期升级风险。

要点

  • BRCA1突变卵巢癌可疑者,常规取卵可能致恶性细胞溢出,不宜行盆腔内卵泡穿刺。
  • 黄体期促性腺激素联合来曲唑刺激后,于触发后34小时行手术分期并离体取卵。
  • 从双侧卵巢切除标本中获得7枚成熟卵母细胞并玻璃化冷冻,同期完成手术分期。

核心结论

  • 作者认为本病例提示对卵巢癌患者可从卵巢切除标本行离体或体外获取成熟卵母细胞,避免盆腔内卵泡穿刺可降低恶性细胞溢出和肿瘤分期升级风险。

研究设计与样本

  • 视频病例报告及文献综述,地点为大学附属中心,患者为37岁单身未产BRCA1突变女性,因右侧复杂卵巢肿块及CA-125升高疑诊卵巢癌并同意完整手术分期。

主要发现

  • 采用黄体期促性腺激素联合来曲唑刺激,于排卵触发后34小时开始手术分期。
  • 在手术分期时直视下从双侧卵巢切除标本行离体取卵,获得7枚成熟卵母细胞并玻璃化冷冻。
  • 同期完成手术分期。

关键数值与推荐

  • 常规取卵因卵泡穿刺会破坏卵巢包膜完整性、增加恶性细胞溢出和肿瘤分期升级风险而被认为不安全。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report a case of ex vivo oocyte retrieval from oophorectomized specimens in a BRCA1 mutation carrier undergoing surgical staging for ovarian cancer. DESIGN: Video case report and literature review. SETTING: University-affiliated center. PATIENT(S): A 37-year-old single woman, gravida 0, with a known BRCA1 mutation, presented to her oncologist with a complex right ovarian mass and elevated CA-125 level. Ovarian cancer was suspected, and the patient consented to complete surgical staging. Although she desired to cryopreserve oocytes for fertility preservation, conventional oocyte retrieval was deemed unsafe because follicular puncture would compromise the integrity of the ovarian capsule, thereby increasing the risk of malignant cell spillage and cancer upstaging. INTERVENTION(S): Luteal-phase ovarian stimulation with gonadotropins and letrozole was performed. Surgical staging was initiated 34 hours after the administration of the ovulatory trigger. MAIN OUTCOME MEASURE(S): Ex vivo retrieval of oocytes from bilateral oophorectomized specimens under direct visualization at the time of surgical staging. RESULT(S): Seven mature oocytes were retrieved and vitrified. Concomitant surgical staging was completed. CONCLUSION(S): The present case highlights the feasibility of ex vivo or extracorporeal retrieval of mature oocytes from oophorectomized specimens in patients with ovarian cancer. By avoiding follicular puncture within the pelvic cavity, it minimizes the risk of malignant cell spillage and cancer upstaging.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Pereira N, Hubschmann AG, Lekovich JP, et al. Ex vivo retrieval and cryopreservation of oocytes from oophorectomized specimens for fertility preservation in a BRCA1 mutation carrier with ovarian cancer. Fertil Steril. 2017. PMID: 28629583. doi:10.1016/j.fertnstert.2017.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。